Schwann Cell Precursors Generate the Majority of Chromaffin Cells in Zuckerkandl Organ and Some Sympathetic Neurons in Paraganglia.
Schwann cell precursors
Zuckerkandl organ
catecholamines
extra-adrenal chromaffin cells
para-aortic sympathetic ganglia
posterior trunk sympathetic ganglia
Journal
Frontiers in molecular neuroscience
ISSN: 1662-5099
Titre abrégé: Front Mol Neurosci
Pays: Switzerland
ID NLM: 101477914
Informations de publication
Date de publication:
2019
2019
Historique:
received:
30
10
2018
accepted:
09
01
2019
entrez:
12
2
2019
pubmed:
12
2
2019
medline:
12
2
2019
Statut:
epublish
Résumé
In humans, neurosecretory chromaffin cells control a number of important bodily functions, including those related to stress response. Chromaffin cells appear as a distinct cell type at the beginning of midgestation and are the main cellular source of adrenalin and noradrenalin released into the blood stream. In mammals, two different chromaffin organs emerge at a close distance to each other, the adrenal gland and Zuckerkandl organ (ZO). These two structures are found in close proximity to the kidneys and dorsal aorta, in a region where paraganglioma, pheochromocytoma and neuroblastoma originate in the majority of clinical cases. Recent studies showed that the chromaffin cells comprising the adrenal medulla are largely derived from nerve-associated multipotent Schwann cell precursors (SCPs) arriving at the adrenal anlage with the preganglionic nerve fibers, whereas the migratory neural crest cells provide only minor contribution. However, the embryonic origin of the ZO, which differs from the adrenal medulla in a number of aspects, has not been studied in detail. The ZO is composed of chromaffin cells in direct contact with the dorsal aorta and the intraperitoneal cavity and disappears through an autophagy-mediated mechanism after birth. In contrast, the adrenal medulla remains throughout the entire life and furthermore, is covered by the adrenal cortex. Using a combination of lineage tracing strategies with nerve- and cell type-specific ablations, we reveal that the ZO is largely SCP-derived and forms in synchrony with progressively increasing innervation. Moreover, the ZO develops hand-in-hand with the adjacent sympathetic ganglia that coalesce around the dorsal aorta. Finally, we were able to provide evidence for a SCP-contribution to a small but significant proportion of sympathetic neurons of the posterior paraganglia. Thus, this cellular source complements the neural crest, which acts as a main source of sympathetic neurons. Our discovery of a nerve-dependent origin of chromaffin cells and some sympathoblasts may help to understand the origin of pheochromocytoma, paraganglioma and neuroblastoma, all of which are currently thought to be derived from the neural crest or committed sympathoadrenal precursors.
Identifiants
pubmed: 30740044
doi: 10.3389/fnmol.2019.00006
pmc: PMC6355685
doi:
Types de publication
Journal Article
Langues
eng
Pagination
6Références
J Neurosci. 1999 May 1;19(9):3519-26
pubmed: 10212311
Genes Dev. 2001 Jan 1;15(1):66-78
pubmed: 11156606
Neuron. 2001 May;30(2):399-410
pubmed: 11395002
Development. 2001 Oct;128(20):3963-74
pubmed: 11641220
Development. 2002 Oct;129(20):4729-38
pubmed: 12361965
Ann N Y Acad Sci. 2002 Oct;971:554-9
pubmed: 12438182
Am J Physiol Heart Circ Physiol. 2003 Jun;284(6):H2069-77
pubmed: 12574001
Mech Dev. 2003 Mar;120(3):299-304
pubmed: 12591599
Mol Cell Neurosci. 2003 Apr;22(4):430-40
pubmed: 12727441
Clin Sci. 1953 Nov;12(4):317-25
pubmed: 13107111
Neuron. 2004 Feb 5;41(3):337-50
pubmed: 14766174
Cell Tissue Res. 2005 Jan;319(1):1-13
pubmed: 15565470
Nat Rev Neurosci. 2005 Sep;6(9):671-82
pubmed: 16136171
Dev Biol. 2006 Oct 15;298(2):335-43
pubmed: 16928368
Am J Physiol Regul Integr Comp Physiol. 2008 Sep;295(3):R942-53
pubmed: 18635452
Glia. 2008 Nov 1;56(14):1479-80
pubmed: 18803316
Genes Dev. 1991 Sep;5(9):1524-37
pubmed: 1909283
Auton Neurosci. 2009 Nov 17;151(1):10-6
pubmed: 19683477
Cell. 2009 Oct 16;139(2):366-79
pubmed: 19837037
J Neurosci. 2010 Jun 30;30(26):8953-64
pubmed: 20592216
J Clin Invest. 2011 Sep;121(9):3412-24
pubmed: 21865647
Development. 2012 Jan;139(2):397-410
pubmed: 22186729
Science. 2012 Jun 22;336(6088):1578-81
pubmed: 22723422
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
J Neuroendocrinol. 2013 Jan;25(1):34-47
pubmed: 23078542
Curr Probl Cancer. 2014 Jan-Feb;38(1):7-41
pubmed: 24636754
J Clin Endocrinol Metab. 2014 Jun;99(6):1915-42
pubmed: 24893135
Science. 2014 Jul 4;345(6192):82-7
pubmed: 24925909
Science. 2014 Jul 4;345(6192):87-90
pubmed: 24925912
Nature. 2014 Sep 25;513(7519):551-4
pubmed: 25079316
Elife. 2014 Sep 25;3:e03696
pubmed: 25255216
Dev Neurobiol. 2016 Feb;76(2):137-49
pubmed: 25989220
J Neurosci. 2015 Jul 8;35(27):9879-88
pubmed: 26156989
Nat Neurosci. 2016 Oct;19(10):1331-40
pubmed: 27571008
Cancer Cell. 2017 Feb 13;31(2):181-193
pubmed: 28162975
Science. 2017 Jul 7;357(6346):
pubmed: 28684471
Dev Biol. 2018 Feb 16;:null
pubmed: 29454705
Cell Tissue Res. 2018 May;372(2):163-170
pubmed: 29623426
Dev Biol. 2018 May 25;:null
pubmed: 29807017
Development. 2018 Nov 2;145(21):null
pubmed: 30237243
Surgery. 1985 Dec;98(6):1121-6
pubmed: 4071388
J Biol Chem. 1995 Nov 10;270(45):27235-43
pubmed: 7592982
Nature. 1995 Apr 13;374(6523):640-3
pubmed: 7715703
Nature. 1995 Apr 13;374(6523):643-6
pubmed: 7715704
Mech Dev. 1993 Aug;42(3):171-85
pubmed: 8217843
J Anat. 1993 Oct;183 ( Pt 2):265-76
pubmed: 8300416
Development. 1993 Dec;119(4):1005-17
pubmed: 8306871
J Neurosci. 1998 Jan 1;18(1):237-50
pubmed: 9412504
Development. 1998 Feb;125(4):599-608
pubmed: 9435281
Development. 1998 Feb;125(4):609-20
pubmed: 9435282